FindTrial
Sign In

A multicenter, bidirectional cohort clinical study evaluating the prognosis of surgery-dominated comprehensive treatment for esophageal cancer using a deep learning model with multimodal feature fusion based on CT and clinical information

A multicenter, bidirectional cohort clinical study evaluating the prognosis of surgery-dominated comprehensive treatment for esophageal cancer using a deep learning model with multimodal feature fusion based on CT and clinical information - Multicenter Bidirectional Cohort Study on Prognosis of Esophageal Cancer Surgery Using a Multimodal Deep Learning Model Based on CT and Clinical Information

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100063
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Training set:None
Testing Group:None
Prospective test set:None

Sponsors

the First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Underwent standardized radical esophagectomy for esophageal cancer; 2. Received standard preoperative and/or postoperative radiotherapy, chemotherapy, or immunotherapy; 3. Pathologically confirmed diagnosis of esophageal cancer; 4. Underwent standard contrast-enhanced chest CT scan within 1 month before surgery; 5. Had complete and available clinical records; 6. Aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1. Poor-quality CT images with artifacts; 2. Received non-standard esophageal cancer treatment (surgery, radiotherapy, chemotherapy, or immunotherapy); 3. Concurrent diagnosis of other malignancies; 4. Perioperative mortality.

Design outcomes

Primary

MeasureTime frame
Overall survival, OS;—

Secondary

MeasureTime frame
Disease free survival, DFS;Progression free survival, PFS;—

Countries

China

Contacts

Public ContactWei Wu

The First Affiliated Hospital of Army Medical University

wuweiyahoo@sohu.com+86 135 9406 6524

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026